home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

The Evolution of Drug Master Files (DMFs)

 
  March 07, 2007  
     
 
Drug Information Association, Online
Mar 19 2007


Gain a Practical Understanding of the Contents, Formats, and Purpose of Drug Master Files (DMFs).

FEATURED TOPICS
•Why DMFs?
•FDA-recognized types of DMFs
•CDER and CBER processes and review of DMFs
•Roles/responsibilities for DMF holders and those who reference DMFs
•Methods of change control
•Suggested formats for DMFs
•Traditional vs. electronic DMFs.

 
 
Organized by: Drug Information Association
Invited Speakers: ARTHUR B. SHAW, P ARTHUR B. SHAW, PHD
Review Chemist and DMF Expert
Office of New Drug Quality Assessment
Division of Pharmaceutical Assessment 1
FDA.

JOHN A ELTERMANN JR., RP JOHN A ELTERMANN JR., RPH
Director Division Manufacturing & Product
Quality CBER, FDA.

 
Deadline for Abstracts: -
 
Registration: http://www.diahome.org/DIAHome/resources/content.aspx?type=eopdf&file=%2fproductfiles%2f13870%2f07207.pdf
E-mail: dia@diahome.org
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.